Davies's Textbook of Adverse Drug Reactions
Davies's Textbook of Adverse Drug Reactions

Author: David Margerison Davies

Publisher: Hodder Education

Published: 1998

Total Pages: 998

ISBN-13:

DOWNLOAD EBOOK

In recent years, a vast amount has been written on adverse drug reactions, yet this surfeit of information has made it more difficult for clinicians to obtain umambiguous answers to their questions. This book provides a "map" for clinicians to find their way through the jungle of tocicological fact and theory. Comprehensive yet succinct, the text deals with matters of fundamental importance, with five new chapters, and extensive revisions of chapters in previous editions. The approach by clinical feature rather than by drug matches the way the problem presents itself to the clinician. This will be invaluable, user-friendly resource for all clinicians.

Mann's Pharmacovigilance
Mann's Pharmacovigilance

Author: Elizabeth B. Andrews

Publisher: John Wiley & Sons

Published: 2014-03-24

Total Pages: 878

ISBN-13: 1118820142

DOWNLOAD EBOOK

Highly Commended at the BMA Medical Book Awards 2015 Mann’s Pharmacovigilance is the definitive reference for the science of detection, assessment, understanding and prevention of the adverse effects of medicines, including vaccines and biologics. Pharmacovigilance is increasingly important in improving drug safety for patients and reducing risk within the practice of pharmaceutical medicine. This new third edition covers the regulatory basis and the practice of pharmacovigilance and spontaneous adverse event reporting throughout the world. It examines signal detection and analysis, including the use of population-based databases and pharmacoepidemiological methodologies to proactively monitor for and assess safety signals. It includes chapters on drug safety practice in specific organ classes, special populations and special products, and new developments in the field. From an international team of expert editors and contributors, Mann’s Pharmacovigilance is a reference for everyone working within pharmaceutical companies, contract research organisations and medicine regulatory agencies, and for all researchers and students of pharmaceutical medicine. The book has been renamed in honor of Professor Ronald Mann, whose vision and leadership brought the first two editions into being, and who dedicated his long career to improving the safety and safe use of medicines.

Adverse Cutaneous Drug Eruptions
Adverse Cutaneous Drug Eruptions

Author: L.E. French

Publisher: Karger Medical and Scientific Publishers

Published: 2012-05-07

Total Pages: 255

ISBN-13: 3805599714

DOWNLOAD EBOOK

The skin is one of the most frequently involved organs in adverse drug reactions. Occurring with an incidence of 1-5% for certain types of drugs, cutaneous drug eruptions are mostly benign in nature, and comprise the maculopapular type of eruption and urticaria. However, about one third of them require hospital treatment, leading to a considerable burden for the health care system.In this book, a selected group of experts provide an up-to-date, condensed and clinically relevant overview of the field of cutaneous drug eruptions, ranging from epidemiology and genetic predisposition to available therapeutic measures, including rapid drug desensitization. Reflecting the great progress made in recent years in this field, this publication will be a useful tool for a better understanding, diagnosis and management of cutaneous drug eruptions, not only for general physicians, dermatologists and clinical allergologists, but also for nurses and scientists.

Adverse Drug Reactions
Adverse Drug Reactions

Author: Anne Lee

Publisher: Pharmaceutical Press

Published: 2006

Total Pages: 504

ISBN-13: 9780853696018

DOWNLOAD EBOOK

Adverse reactions to medicines continue to present a burden on healthcare, causing considerable morbidity and mortality. Aswell as knowing about the benefits of medicines, healthcare professionals need to understand the problem of adverse drugreactions and be aware of how they can be prevented and managed. This essential and practical guide has been extensively revised and updated to include three new chapters on adverse effectsof drugs in pregnancy, pharmacogenetics, and side effects and patients. Case studies are provided with each chapter.

Assessment of Long-Term Health Effects of Antimalarial Drugs When Used for Prophylaxis
Assessment of Long-Term Health Effects of Antimalarial Drugs When Used for Prophylaxis

Author: National Academies of Sciences, Engineering, and Medicine

Publisher: National Academies Press

Published: 2020-04-24

Total Pages: 427

ISBN-13: 0309672104

DOWNLOAD EBOOK

Among the many who serve in the United States Armed Forces and who are deployed to distant locations around the world, myriad health threats are encountered. In addition to those associated with the disruption of their home life and potential for combat, they may face distinctive disease threats that are specific to the locations to which they are deployed. U.S. forces have been deployed many times over the years to areas in which malaria is endemic, including in parts of Afghanistan and Iraq. Department of Defense (DoD) policy requires that antimalarial drugs be issued and regimens adhered to for deployments to malaria-endemic areas. Policies directing which should be used as first and as second-line agents have evolved over time based on new data regarding adverse events or precautions for specific underlying health conditions, areas of deployment, and other operational factors At the request of the Veterans Administration, Assessment of Long-Term Health Effects of Antimalarial Drugs When Used for Prophylaxis assesses the scientific evidence regarding the potential for long-term health effects resulting from the use of antimalarial drugs that were approved by FDA or used by U.S. service members for malaria prophylaxis, with a focus on mefloquine, tafenoquine, and other antimalarial drugs that have been used by DoD in the past 25 years. This report offers conclusions based on available evidence regarding associations of persistent or latent adverse events.

Oxford Textbook of Anaesthesia
Oxford Textbook of Anaesthesia

Author: Jonathan G. Hardman

Publisher: Oxford University Press

Published: 2017-06-27

Total Pages: 1630

ISBN-13: 0199642044

DOWNLOAD EBOOK

This new definitive resource addresses the fundamental principles of anaesthesia, underpinning sciences and the full spectrum of clinical anaesthetic practice. An international team of experts provide trustworthy, effective, and evidence-based guidance enabling clinicians to provide the very best clinical care to patients.

Davis's Drug Guide for Rehabilitation Professionals
Davis's Drug Guide for Rehabilitation Professionals

Author: Charles D. Ciccone

Publisher: F.A. Davis

Published: 2013-03-21

Total Pages: 1217

ISBN-13: 0803640048

DOWNLOAD EBOOK

A one-of-a-kind guide specifically for rehabilitation specialists! A leader in pharmacology and rehabilitation, Charles Ciccone, PT, PhD offers a concise, easy-to-access resource that delivers the drug information rehabilitation specialists need to know. Organized alphabetically by generic name, over 800 drug monographs offer the most up-to-date information on drug indications, therapeutic effects, potential adverse reactions, and much more! A list of implications for physical therapy at the end of each monograph helps you provide the best possible care for your patients. It’s the perfect companion to Pharmacology in Rehabilitation, 4th Edition!

The Actions and Uses of Ophthalmic Drugs
The Actions and Uses of Ophthalmic Drugs

Author: P. H. O'Connor Davies

Publisher: Elsevier

Published: 2013-10-22

Total Pages: 407

ISBN-13: 1483192202

DOWNLOAD EBOOK

The Actions and Uses of Ophthalmic Drugs: A Textbook for Students and Practitioners, Second Edition provides pertinent information in relation to concepts in pharmacology, the formulation and application of ophthalmic drugs, and adverse ocular effects of systemic medication. This book discusses the preparations used in contact lens practice. Organized into 17 chapters, this edition begins with an overview of the primary systems of drug classification according to their actions or effects, or on the basis of their chemistry. This text then presents a detailed discussion on the actions and uses of ophthalmic autonomic drugs. Other chapters consider the structure and function of the involuntary nervous system in the orbital region. This book discusses as well the two main classifications of ophthalmic drugs, namely, therapeutic and diagnostic. The final chapter deals with the clinical significance of medication-induced ocular adverse effects. This book is a valuable resource for ophthalmologists, students, and practitioners.

Pain Management and the Opioid Epidemic
Pain Management and the Opioid Epidemic

Author: National Academies of Sciences, Engineering, and Medicine

Publisher: National Academies Press

Published: 2017-09-28

Total Pages: 483

ISBN-13: 0309459575

DOWNLOAD EBOOK

Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.